Evidence for Linkage between Regulatory Enzymes in Glycolysis and Schizophrenia in a Multiplex Sample

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 127 B, Issue 1, 2004, Pages 5-10

  Stone, William S ^a,b,e   Faraone, Stephen V ^a,b   Su, Jessica ^a,b   Tarbox, Sarah I ^a,d   Van Eerdewegh, Paul ^a,c   Tsuang, Ming T ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Harvard Inst Psychiat E/G   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e MASSACHUSETTS MENTAL HEALTH CENTER   (United States)

Author keywords

Genetics; Glycolysis; Hexokinase; Linkage; Phosphofructokinase; Schizophrenia

Indexed keywords

6 PHOSPHOFRUCTO 2 KINASE; FRUCTOSE 2,6 BISPHOSPHATASE; HEXOKINASE; PYRUVATE KINASE;

AFRICAN AMERICAN; ARTICLE; CHROMOSOME 1Q; CHROMOSOME 5Q; CONTROLLED STUDY; EUROPEAN AMERICAN; GENETIC LINKAGE; GLUCOSE HOMEOSTASIS; GLYCOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MARKER GENE; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 2142653598     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.20132     Document Type: Article

References (40)

1. Baptista T, Kin NMKNY, Beaulieu S, de Baptista EA. 2001a. Obesity and related metabolic abnormalities during antipsychotic drug administration: Mechanisms, manangement, and research perspectives. Pharmacopsychiatry 35:207-219.
2. Baptista T, Lacruz A, Angeles F, Silveira J, de Mendoza S, Hernanedz X. 2001b. Endocrine and metabolic abnormalities involved in obesity associated with typical antipsychotic drug administration. Pharmacopsychiatry 34:223-231.
3. Braceland FJ, Meduna LJ, Vaichulis JA. 1945. Delayed action of insulin in schizophrenia. Am J Psychiatry 102:108-110.
4. Brambilla F, Guastalla A, Guerrini A, Riggi F, Rovere C, Zanobonl A, Zenobonl-Muckaccia L. 1976. Glucose-insulin metabolism in chronic schizophrenia. Dis Nerv Syst 37:98-103.
5. Brzustowicz LM, Hodgkinson KA, Chow EWC, Honer WG, Basett AS. 2000. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 288:678-682.
6. Cassidy F, Ahearn E, Carroll BJ. 1999. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry 156:1417-1420.
7. Cloninger CR, Kaufmann CA, Faraone SV, Malaspina D, Svrakic DM, Harkavy-Fredman J, Suarez X, Matise TC, Shore D, Lee H, Hampe CL, Wynne D, Drain C, Markel PD, Zambuto CT, Schultz SK, Tsuang MT. 1998. A genome-wide search for schizophrenia susceptibility loci: The NIMH genetics initiative & Millennium Consortium. Am J Med Genet Neuropsychiatr Genet 81:275-281.
8. Cramond WA. 1987. Lessons from the insulin story in psychiatry. Aust N Z J Psychiatry 21:320-326.
9. Davis SK, Liu Y, Gibbons GH. 2003. Disparities in trends of hospitalization for potentially preventable chronic conditions among African-Americans during the 1990s: Implications and benchmarks. Am J Public Health 93:447-455.
10. Eaton WW. 2002. Epidemiologic evidence on the comorbidity of depression and diabetes. J Psychosom Res 53:903-906.
11. Faraone SV, Su J, Taylor L, Wilcox M, Van Eerdewegh P, Tsuang MT. A genome scan of smoking intensity in schizophrenia families (submitted).
12. Faraone SV, Matise T, Svrakic D, Pepple J, Malaspina D, Svarez B, Hempe C, Zambuto CT, Schultt K, Meyer J, Markel P, Lee H, Harkavy-Freedman J, Kaufmann C, Cluminger CR, Tsuang MT. 1998. Genome scan of European-American schizophrenia pedigrees: Results of the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet (Neuropsychiatr Genet) 81:290-295.
13. Franzen G, Nilsson L. 1968. A study of blood sugar response to insulin injection in schizophrenia. Acta Psychiatr Scand 44:24-26.
14. Freedman R, Leonard S, Olincy A, et al. 2001. Evidence for the multigenic inheritance of schizophrenia. Neuropsychiatr Genet 105:794-800.
15. Fucetola R, Newcomer JW, Craft S, Melson AK. 1999. Age- and dose-dependent glucose-induced increases in memory and attention in schizophrenia. Psychiatry Res 88:1-13.
16. Ganzini L, Heintz R, Hoffman W, Casey D. 1991. The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. Arch Gen Psychiatry 48:259-263.
17. Gottesman II. 2001. Psychopathology through a life span-genetic prism. Am Psychol 56:867-878.
18. Hagg S, Joelsson L, Mjorndal T, Spigset O, Oja G, Dahlqvist R. 1998. Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications. J Clin Psychiatry 59:294-299.
19. Hall JL, Gonder-Frederick LA, Chewning WW, Silveira J, Gold PE. 1989. Glucose enhancement of performance on memory tests in young and aged humans. Neuropsychologia 27:1129-1138.
20. Haupt D, Newcomer J. 2001. Hyperglycemia and antipsychotic medications. J Clin Psychiatry 62(Suppl 27):15-26.
21. Henderson DC. 2001. Clozapine: Diabetes mellitus, weight gain, and lipid abnormalities. J Clin Psychiatry 62(Suppl 23):39-44.
22. Kooy FH. 1919. Hyperglycemia in mental disorders. Brain 17:214-289.
23. Lozovsky DB, Kopin IJ, Saller CF. 1985. Modulation of dopamine receptor supersensitvity by chronic insulin: Implications in schizophrenia. Brain Res 343:190-193.
24. McGuffin P, Sargeant M, Hetti G, Tidmarsh S, Whatley S, Marchbanks RM. 1990. Exclusion of a schizophrenia susceptibility, gene from the chromosome 5q11-q13 region: New data and a reanalysis of previous reports. Am J Hum Genet 47:524-535.
25. Messier C, Desrochers A, Gagnon M. 1999. Effect of glucose, glucose regulation, and word imagery value on human memory. Behav Neurosci 113:431-438.
26. Mukherjee S, Roth S, Sandyk R, Schnur D. 1989. Persistent tardive dyskinesia and neuroleptic effects on glucose tolerance. Psychiatry Res 29:17-27.
27. Newcomer JW, Craft S, Fucetola R, Fucetola R, Molen SO, Salke G, Parra EJ, Mellat X. 1999. Glucose-induced increase in memory performance in patients with schizophrenia. Schizophr Bull 25:321-335.
28. Newcomer JW, Haupt DW, Fucetola R, Melson AK, Schweger JA, Cooper BP, Salke G. 2002. Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch Gen Psychiatry 59:337-345.
29. Nyirenda M, Lindsay R, Kenyon C, Burchell A, Seckl J. 1998. Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Investig 101:2174-2181.
30. Okar DA, Manzano A, Navarro-Sabate A, Riera L, Bartrons R, Lange AJ. 2001. PFK-2/FBOase-2: Maker and breaker of the essential biofactor fructose-2,6 bisphosphate. Trends Biochem Sci 26:30-35.
31. Pfaff CL, Parra EJ, Bonilla C, Hiester K, Mckeique PM, Kambah MI, Hutchinson RG, Ferrell RE, Boerwinkle E, Sheiver X. 2001. Population structure in admixed populations: Effect of admixture on the pattern of linkage disequilibrium. Am J Hum Genet 68:198-207.
32. Popli AP, Konicki PE, Jurjus GJ, Fuller MA, Jaskiw GE. 1997. Clozapine and associated diabetes mellitus. J Clin Psychiatry 58:108-111.
33. Regenold WT, Thapar RK, Marano C, Gavirneni S, Kondapavuluru PV. 2002. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord 70:19-26.
34. Schimmelbusch W, Mueller P, Sheps J. 1971. The positive correlation between insulin resistance and duration of hospitalization in schizophrenia. Br J Psychiatry 118:429-436.
35. Schultz SK, Arndt S, Ho B-C, Oliver SE, Andreasen NC. 1999. Impaired glucose tolerance and abnormal movements in patients with schizophrenia. Am J Psychiatry 156:640-642.
36. Smith MW, Lautenberger JA, Shin HD, Chretain J-P, Sretha S, Gilbert DA, O'Brian SJ. 2001. Markers for mapping by admixture linkage disequilibrium in African-American and Hispanic samples. Am J Hum Genet 69:1080-1094.
37. Steppan C, Bailey S, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazan MA. 2001. The hormone resisten links obesity to diabetes. Nature 409:307-312.
38. Stone WS, Seidman LJ, Wojcik JD, Green AI. Glucose effects on cognition in schizophrenia. Schizophr Res 62:93-103.
39. Stone WS, Wenk GL, Olton DS, Gold PE. 1990. Poor blood glucose regulation predicts sleep and memory deficits in normal aged rats. J Gerontol Biol Sci 45:B169-B173.
40. Taniguchi A, Nakai Y, Yoshii S, Hamanaka D, Hatae Y, Kawata M, Yamanouchi K, Okumvia T, Doi K, Tokuyama K, Nagasaka S, Fukushima M. 2002. Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese type 2 diabetic patients. Metab Clin Exp 51:544-548.